Mesenchymal cell condensation is the initiating event in endochondral bone formation. Cell condensation is followed by differentiation into chondrocytes, which is accompanied by induction of chondrogenic gene expression. Gene mutations involved in chondrogenesis cause chondrodysplasias and other skeletal defects. Using mesenchymal stem cells (MSCs) in an in vitro chondrogenesis assay, we found that knockdown of the diastrophic dysplasia (DTD) sulfate transporter (DTDST, also known as SLC26A2), which is required for normal cartilage development, blocked cell condensation and caused a significant reduction in fibronectin matrix. Knockdown of fibronectin with small interfering RNAs (siRNAs) also blocked condensation. Fibrillar fibronectin matrix was detected prior to cell condensation, and its levels increased during and after condensation. Inhibition of fibronectin matrix assembly by use of the functional upstream domain (FUD) of adhesin F1 from Streptococcus pyogenes prevented cell condensation by MSCs and also by the chondrogenic cell line ATDC5. Our data show that cell condensation and induction of chondrogenesis depend on fibronectin matrix assembly and DTDST, and indicate that this transporter is required earlier in chondrogenesis than previously appreciated. They also raise the possibility that certain of the skeletal defects in DTD patients might derive from the link between DTDST, fibronectin matrix and condensation.
INTRODUCTION
Cartilage development is initiated by aggregation of undifferentiated mesenchyme into a condensed mass of cells. These condensed cells undergo differentiation to form chondrocytes that deposit cartilagespecific extracellular matrix (ECM). Differentiated chondrocytes can follow two fates: one is to continue to proliferate and maintain a cartilaginous structure and function, the second is to undergo hypertrophy. Hypertrophic chondrocytes undergo apoptosis leaving behind a mineralized matrix that acts as a template for osteoblasts (Lefebvre and Bhattaram, 2010; Singh and Schwarzbauer, 2012; Sundelacruz and Kaplan, 2009) . One of the key features of chondrogenesis is a temporal change in the composition of the deposited ECM . During condensation, matrix proteins such as fibronectin, collagen I and the proteoglycan versican are prevalent (Dessau et al., 1980; Kamiya et al., 2006; Kimata et al., 1986; Kulyk et al., 1991) . In contrast, matrix deposited by differentiated chondrocytes is rich in collagens II and IX and the proteoglycan aggrecan (Choocheep et al., 2010; Knudson and Knudson, 2001; Knudson and Toole, 1985; Kravis and Upholt, 1985; Kulyk et al., 1991) ; this matrix might provide the optimal stiffness, which is known to be important for chondrocyte differentiation (Allen et al., 2012) .
Mesenchymal condensation is a prerequisite for chondrogenesis and is facilitated by cell adhesion molecules (Barna and Niswander, 2007; Bobick et al., 2009; DeLise et al., 2000) . Upregulation of the cell-cell adhesion proteins N-cadherin and neural cell adhesion molecule (N-CAM) is a hallmark of condensing cells (Bobick et al., 2009; Singh and Schwarzbauer, 2012) and condensation is reduced with loss of N-cadherin function (Bobick et al., 2009; DeLise and Tuan, 2002a; DeLise and Tuan, 2002b) . Among the matrix proteins, fibronectin is abundant in mesenchyme and is upregulated during condensation in vivo and in vitro (Dessau et al., 1980; Kulyk et al., 1989) . Interactions involving the N-terminal domain of fibronectin and heparinase-sensitive molecules on mesenchymal cell surfaces have been implicated in condensation (Frenz et al., 1989) . Fibronectin is a ubiquitous ECM protein that is assembled into a fibrillar matrix through a cell-mediated process, and links cells with collagens and other ECM proteins (Kadler et al., 2008; Singh and Schwarzbauer, 2012) . However, an essential role for fibronectin matrix assembly during precartilage condensation has not been demonstrated.
Diastrophic dysplasia sulfate transporter (DTDST, also known as SLC26A2) has an essential role in the sulfation of glycosaminoglycans (GAGs) on cartilage proteoglycans, and mutations in human DTDST result in skeletal defects including achondrogenesis and chondrodysplasias (Rossi and SupertiFurga, 2001) . A DTDST knock-in mutant mouse model that disrupts DTDST function leads to defects in chondrocyte size, proliferation and terminal differentiation (Forlino et al., 2005; Gualeni et al., 2010) . DTDST is also required for fibronectin matrix assembly by HT1080 fibrosarcoma cells (Galante and Schwarzbauer, 2007) suggesting that it might play a role prior to chondrocyte differentiation at a time when fibronectin matrix is being assembled.
A micromass culture technique is commonly used to study the mechanisms of chondrogenesis in vitro because it recapitulates the cell condensation and early differentiation stages. We utilized bone-marrow-derived mesenchymal stem cells (MSCs) and the chondrogenic cell line ATDC5 to assess the role of fibronectin during condensation. We show that a fibronectin matrix is present before, during and after condensation. Assembly of fibronectin into a matrix is dependent on DTDST and plays an essential role in the condensation process.
RESULTS

Timing of cell condensation after induction of chondrogenesis
MSCs were induced to initiate chondrogenic differentiation using high-density micromass cultures in chondrogenic medium containing TGFb3. Cell rearrangements were visualized by time-lapse video microscopy ( Fig. 1A ; supplementary material Movie 1). The process of condensation began as early as 2 h after induction when cells interacted with neighboring cells to form small interconnected cell clusters (Fig. 1A, 3 h 40 m) , which subsequently coalesced (Fig. 1A, 7 h 20 m) and condensed within 11 h to form a single opaque cohesive mass of cells (Fig. 1A, 10 h 40 m) . The cell condensate usually detached from the substrate into the chondrogenic medium. For video microscopy, micromass cultures were plated on a glassbottomed culture dish. When plated on tissue culture plastic, the process was slightly slower. Across 17 micromass cultures on tissue culture plastic dishes, condensation was complete between 14 and 16 h. The progression of condensation was confirmed by increased staining at 24 h with fluorescent peanut agglutinin, which detects precartilage cell aggregates and is a marker of condensation (Aulthouse and Solursh, 1987) (Fig. 1B) . Uninduced MSCs grown in a monolayer showed negligible staining with peanut agglutinin (data not shown). N-cadherin is required for condensation to occur, but is subsequently downregulated during differentiation (Bobick et al., 2009; Oberlender and Tuan, 1994; Woods et al., 2007) . Our results show completion of condensation within 24 h and, given that differentiation follows over a period of days, cell lysates were prepared over an 8-day time course. We found that N-cadherin protein was increased during the first 24 h and then declined gradually over the next 7 days (Fig. 1C) .
To show the initiation of the chondrogenic differentiation program, quantitative RT-PCR (qPCR) was used to follow changes in the gene expression of sex determining region (SRY) box 9 (Sox9) during and after condensation [Sox9 is an essential transcription factor for chondrogenic differentiation (Bi et al., 1999; Healy et al., 1999) ]. Sox9 was upregulated more than 6-fold within 8 h and further increased to 9-fold by 16 h, when condensation was complete. Post-condensation expression levels of Sox9 were downregulated from this peak by ,2.5-fold by 48 h and then were maintained at that level for at least 6 days after induction ( Fig. 2A) . Accumulation of GAGs in the ECM is a marker for chondrogenesis (Knudson and Knudson, 2001 ). GAGs detected with Alcian Blue dye increased from 18 to 48 h (Fig. 2B) . Together, the cell rearrangements observed by timelapse microscopy, the expression changes for N-cadherin and Sox9, and increased GAG deposition and lectin binding match the previously reported changes during condensation and chondrogenesis in vivo and in vitro (Barna and Niswander, 2007; Bobick et al., 2009; Brady et al., 2013; Chen et al., 2009; DeLise and Tuan, 2002b; Oberlender and Tuan, 1994) . Taken together, the results in Figs 1 and 2 show that MSCs in micromass culture condense within the first 24 h and then undergo chondrogenic differentiation over the following days.
DTDST is required for MSC condensation
DTDST plays an important role in cartilage development and homeostasis (Forlino et al., 2005; Rossi and Superti-Furga, 2001 ). To test whether this transporter is required for condensation, expression was knocked down in MSCs using DTDST small interfering RNAs (siRNAs) (Galante and Schwarzbauer, 2007) . Quantitative RT-PCR (qPCR) showed that there was a more than 70% reduction in DTDST mRNA with this treatment (Fig. 3A) . Condensation of siRNA-treated cells was significantly impaired compared to mock-treated control cells (Fig. 3B) . Four out of four mock-treated cultures condensed, whereas none of the DTDST-knockdown cultures (0/4) condensed by 3 days. Therefore, in addition to its established role in the later stages of cartilage development, DTDST is required for the early, condensation, stage of chondrogenesis. We have previously shown that fibronectin matrix assembly depends on the fibronectin-binding proteoglycan syndecan-2 and proteoglycan sulfation downstream of DTDST (Galante and Schwarzbauer, 2007) . Therefore, we tested whether the condensation defects observed with DTDST knockdown were correlated with defects in fibronectin matrix assembly. Day 3 micromass cultures were solubilized in buffer containing the detergent deoxycholate (DOC); mock-treated micromass cultures were condensed by that time but DTDST-knockdown cultures were not. During matrix assembly, fibronectin is initially assembled into fibrils that are soluble in DOC. DOC-soluble fibronectin levels in these lysates were significantly decreased with DTDST siRNA treatment (Fig. 3C) . Quantification of band intensities showed that DOC-soluble fibronectin was reduced 3-fold compared to the control (Fig. 3D ). DTDST knockdown does not change fibronectin expression levels (data not shown). Thus, there is a strong correlation between loss of condensation and reduction in fibronectin matrix assembly upon knockdown of DTDST.
Fibronectin matrix assembly during condensation
The noticeable reduction in fibronectin matrix in DTDSTknockdown cells (Fig. 3C ,D) and the reported increase in fibronectin mRNA levels during condensation in chick limb buds (Kulyk et al., 1989 ) led us to examine MSC fibronectin during condensation and differentiation in micromass cultures. qPCR was performed with RNA isolated over the time course of condensation and differentiation. Fibronectin is expressed by undifferentiated MSCs (data not shown) and its expression is maintained throughout condensation. Levels increased postcondensation, as detected at 24 and 48 h (Fig. 4A) . In order to determine the fate of fibronectin, we investigated fibronectin matrix assembly by immunofluorescence staining of micromass cultures or sections of differentiating cell aggregates. Fibronectin matrix fibrils were evident prior to condensation and as early as 6 h in micromass culture (Fig. 4B ). Fibronectin matrix continues to accumulate throughout condensation and differentiation, as shown by staining of day 3 and day 6 cell aggregates ( Fig. 4C) . Therefore, MSCs express and assemble fibronectin into a matrix throughout condensation and differentiation. Comparison of these results to those in Fig. 1B and Fig. 2 shows that fibronectin assembly occurs concomitantly with changes in condensation and chondrogenic markers. The assembly of fibrillar fibronectin matrix prior to and during the time that cells are condensing suggests that fibronectin matrix might play a role in the condensation process.
Condensation is blocked by fibronectin knockdown
To determine whether fibronectin matrix is required for condensation, we used fibronectin siRNA transfection to knockdown its expression in MSCs. This treatment had no obvious morphological effect on MSCs grown under nondifferentiating conditions (data not shown). MSCs treated with fibronectin siRNA that were induced to undergo chondrogenesis showed a significant reduction in fibronectin in the cell conditioned medium and in whole-cell lysates compared to mock-treated cells (Fig. 5A ). Therefore, siRNA treatment efficiently knocks down fibronectin expression and reduces or eliminates fibronectin matrix. Fibronectin-siRNA-treated cells in a micromass culture showed delayed condensation ( KD). The number of condensed cultures increased to 9 out of 11 by day 4. When exogenous fibronectin was added to the cells treated with fibronectin siRNA, the majority of cultures had condensed by day 3 (12 out of 15; Fig. 5B, FN KD+FN) ; the number of condensed cultures increased to 14 out of 15 by day 4 in these conditions. These results show that fibronectin expression promotes cell condensation and that condensation can be rescued in fibronectin-knockdown cultures by addition of fibronectin. It seems likely that condensation is delayed instead of completely blocked by fibronectin siRNA, because fibronectin expression is gradually restored in these cultures.
Condensation depends on fibronectin matrix assembly
To distinguish between a requirement for fibronectin expression and fibronectin matrix assembly during cell condensation, we used a 49-amino-acid peptide from the functional upstream domain (FUD) of adhesin F1 of Streptococcus pyogenes to disrupt the assembly process. FUD binds to the N-terminal assembly domain of fibronectin and prevents the fibronectinfibronectin interactions that are essential for matrix assembly ) but does not affect fibronectin expression (Chiang et al., 2009 ; data not shown). The III-11C peptide derived from the III-11 module of fibronectin was used as a control (Bourdoulous et al., 1998; Chiang et al., 2009) . Treatment of MSCs with FUD for 24 h in a monolayer culture blocked matrix assembly (Fig. 6A) . Similarly, FUD reduced the incorporation of fibronectin into matrix fibrils in micromass cultures at 8 h, just prior to condensation (Fig. 6B ). Fibronectin matrix levels in an SDS lysate of a FUD-treated micromass culture were also reduced compared to III-11C treatment ( Fig. 6C ) with 6-fold lower fibronectin levels in lysates of FUD-treated micromass cultures compared to III-11C-treated cultures (Fig. 6D) . Seven FUD-treated micromass cultures failed to condense within 3 days whereas seven out of seven of the III-11C-treated cultures had condensed by 24 h (Fig. 7A) . Timelapse video microscopy of the condensation process in the presence of FUD shows that cells formed clusters, but that these clusters failed to merge to form one condensed cell mass ( Fig. 7B ; supplementary material Movie 3), whereas those with III-11C formed clusters that merged to form one cell condensate ( Fig. 7B ; supplementary material Movie 2). These results show that inhibition of fibronectin matrix assembly is sufficient to inhibit condensation.
To test whether the role for fibronectin matrix in condensation was more generally applicable, we used ATDC5 cells, which condense into nodules when stimulated with insulin-transferrinselenium (Fig. 8A) . Cultures with and without FUD were followed for 21 days. Nodule formation became apparent after 12 days of induction, and the number and size of nodules continued to increase up to day 21 when total number of nodules was scored. With III-11C-treated ATDC5 cells, 35 nodules were detected, but only six nodules were observed in the FUD-treated cultures (Fig. 8B) . Fibronectin matrix levels were also reduced in the FUDtreated ATDC5 cultures (Fig. 8C) . Thus, the requirement for fibronectin matrix in condensation is not specific to the cell type because both MSCs and ATDC5 cells did not condense when fibronectin matrix assembly was prevented.
DISCUSSION
Mesenchymal condensation is a prerequisite for chondrogenesis and is facilitated by cell adhesion molecules. Here, we show an essential role for fibronectin matrix assembly, which is dependent on the sulfate transporter DTDST. Fibronectin is expressed and fibronectin matrix is assembled prior to and during condensation, and fibronectin matrix continues to accumulate during the postcondensation differentiation process. Knockdown of DTDST prevented condensation of micromass cultures concomitantly with reducing fibronectin matrix levels. Direct blockade of fibronectin matrix assembly completely inhibited condensation. Similar results were obtained using two distinctly different cell lines, mesenchymal stem cells and the ATDC5 chondrogenic cell line. Our results show that fibronectin fibril assembly is an important factor in bringing cells together at the earliest stage of mesenchymal cell differentiation into chondrocytes.
Fibronectin mRNA and protein levels are upregulated at the time of condensation in chick limb-bud mesenchyme (Dessau et al., 1980; Kulyk et al., 1989) . Fibronectin is present in areas of chick limbs where condensed cells are differentiating, as well as in growth plate cartilage in chick and mouse (Bobick et al., 2009; Gehris et al., 1997; Imai et al., 2007; Melnick et al., 1981; Singh and Schwarzbauer, 2012 , and our unpublished results). Fibronectin splice variants also change during condensation and differentiation, although what specific functions these variants perform has not been fully elucidated (White et al., 2003) . Our results show that a crucial function for fibronectin in condensation is matrix assembly. The N-terminal domain of fibronectin has previously been implicated in condensation, and the activity of this domain was attributed to interactions with cell surface heparin-like moieties but not to its role in matrix assembly (Frenz et al., 1989) . FUD binds to the N-terminal domain of fibronectin but does not compete with heparin for binding . Therefore, our results showing the inhibition of condensation by FUD clearly connect matrix assembly with condensation independent of heparin binding to the N-terminal domain.
In addition to its early role in promoting condensation, fibronectin matrix is continuously present post-condensation and in cartilage, suggesting that fibronectin has temporally distinct roles in this tissue. Given that fibronectin matrix acts as a platform for type I collagen deposition (Kadler et al., 2008; Singh et al., 2010) , one possibility is that fibronectin matrix has a similar role in type II collagen assembly during chondrocyte differentiation. Fibronectin matrix might also contribute to the chondrogenic differentiation program through effects on Sox9 expression. We observed a 25% reduction in Sox9 mRNA levels with 24 h of FUD treatment compared to in III-11C-treated cells (P.S., unpublished observations) indicating that matrix assembly might enhance Sox9 expression. We have previously shown that mammary epithelial to mesenchymal transition depends on synergy between fibronectin and TGFb signals (Park and Schwarzbauer, 2014) . It is also possible that differentiation or maintenance of chondrocytes depends on synergistic signaling between fibronectin matrix and chondrogenic factors, such as bone morphogenetic proteins (BMPs) or TGFb.
The process of condensation is governed by cell-cell interactions. N-cadherin is transiently upregulated during cell condensation and declines thereafter (DeLise and Tuan, 2002b) . N-CAM is also enriched in cells undergoing condensation (Widelitz et al., 1993) . Condensation and subsequent differentiation in micromass cultures are perturbed by cell manipulations that block N-CAM or N-cadherin homotypic interactions or that prevent connections through the cytoplasmic domain of N-cadherin (Bobick et al., 2009; DeLise and Tuan, 2002a; DeLise and Tuan, 2002b; Widelitz et al., 1993) . In the absence of N-cadherin, such as in N-cadherin-null limb bud explants, condensation is not affected and proceeds through compensation by cadherin-11 (Luo et al., 2005) . As in other studies, our results also show transient upregulation of Ncadherin that coincides with the condensation timeline and with the early stages of fibronectin matrix assembly. Both cadherins and fibronectin matrix have been shown to be important for cellcell cohesion (Robinson et al., 2004; Robinson et al., 2003) , and fibronectin matrix assembly has been shown to decrease Ncadherin adhesion in fibroblasts (Lefort et al., 2011) . The temporal connection between N-cadherin and fibronectin matrix suggests cooperation during condensation between these two adhesion systems. Any cooperation does not appear to be at the level of expression because N-cadherin protein levels were the same in FUD-treated and III-11C-treated micromass cultures undergoing condensation (P.S., unpublished observations).
Fibronectin matrix assembly is also linked to chondrogenesis through the role of DTDST in this process. Mutations in this transporter cause a variety of chondrodysplasias of varying severity including diastrophic dysplasia (DTD), multiple epiphyseal dysplasia, atelosteogenesis type 2 and achondrogenesis 1B (Karniski, 2001; Superti-Furga et al., 1996a; Superti-Furga et al., 1996b) . Sulfated proteoglycans are abundant in cartilage matrix (Knudson and Knudson, 2001 ) and a main molecular defect in DTD patients is under-sulfation of cartilage proteoglycans. We previously found that sulfate deficiency dramatically reduces fibronectin matrix assembly by fibrosarcoma cells and linked this matrix defect to DTDST and syndecan-2, a fibronectin-binding, transmembrane proteoglycan (Galante and Schwarzbauer, 2007) . Knockdown of DTDST in fibrosarcoma cells reduces fibronectin matrix, and expression of a DTDST transgene promotes fibronectin assembly, showing the importance of this transporter in facilitating the assembly process (Galante and Schwarzbauer, 2007) . Here, we showed that loss of DTDST reduces fibronectin matrix as it impairs mesenchymal cell condensation. This condensation defect occurs earlier in cartilage development than the previously characterized under-sulfation defects suggesting that DTDST might have multiple roles during chondrogenesis. Not only have we identified early roles for DTDST and fibronectin matrix in chondrogenesis, but the link to fibronectin matrix raises the possibility that effects of mutations in DTDST that cause chondrodysplasias might be mediated in part by its effect on fibronectin matrix during cartilage development. 
MATERIALS AND METHODS
Cell culture
Bone-marrow-derived MSCs, obtained from Lonza (Walkersville, MD, USA), had been confirmed as positive for stem cell markers and negative for lineage-specific markers by flow cytometry and were certified for differentiation as described by Lonza. In addition to our chondrogenesis experiments, we also verified their ability to undergo differentiation along adipogenic and osteogenic lineages (data not shown). MSCs were maintained in an undifferentiated state by culturing in defined mesenchymal stem cell basal medium (MSCBM) containing 10% serum plus growth supplements, L-glutamine and GA1000 (Lonza). Cells were passaged at 80-90% confluence and replated at a density of 5000-6000 cells/cm 2 . Cells were used for experiments up to passage eight. The ATDC5 cell line (Sigma, St Louis, MO, USA) was grown in maintenance medium, which is DMEM and F12 (1:1; Life Technologies, Grand Island, NY, USA) supplemented with 5% fetal bovine serum (Hyclone, Logan, UT, USA). All cultures were grown at 37˚C and under 5% CO 2 .
In vitro chondrogenesis assay
To establish high-density cultures for chondrogenesis, MSCs grown in monolayer were trypsinized, counted and then induced in either micromass culture or pellet culture. Chondrogenic differentiation medium is composed of chondrogenic basal medium supplemented with dexamethasone, ascorbate, insulin-transferrin-selenium (ITS) supplement plus GA1000, sodium pyruvate, proline and L-glutamine (Lonza); TGFb3 was added at 10 ng/ml (Lonza). Differentiation medium is serum-free, so all fibronectin present in the condensing cultures is produced by the MSCs. For pellet culture, 2610 5 cells in chondrogenic differentiation medium without TGFb3 were centrifuged at 160 g for 5 min, cells were resuspended in chondrogenic differentiation medium with TGFb3 and then centrifuged again to form a cell pellet (as recommended in the Lonza protocol). For micromass cultures, 50,000, 70,000 or 100,000 cells in 10 ml of MSCBM were plated on tissue culture plastic for 45 min, to allow adhesion, and then chondrogenic differentiation medium containing TGFb3 was added. For establishing the condensation time line, each independent experiment was performed using four or five micromass cultures.
ATDC5 cells were either plated at 4610 4 cells/well in a 12-well plate or 6610 4 cells/well in a six-well plate in maintenance medium and allowed to grow to confluence for 4 days prior to adding differentiation medium. Differentiation medium is maintenance medium supplemented with ITS (Life Technologies, Grand Island, NY). Nodules were counted at day 21.
In experiments with peptide addition, III-11C or FUD peptide was added with differentiation medium. Both III-11C and FUD were used at 0.3 mM. His-tagged III-11C and the FUD were purified as described previously (Hunt et al., 2012) .
Quantitative RT-PCR
Cells were lysed in Trizol reagent (Life Technologies, Grand Island, NY, USA) and, after chloroform extraction and ethanol precipitation, RNA was subjected to RNeasy purification according to the manufacturer's instructions (Qiagen, Hilden, Germany). 500 ng of total RNA was reversed transcribed using random hexamer primers and Superscript II reverse transcriptase (Life Technologies, Grand Island, NY, USA). Primers for real-time PCR were designed using Mac Vector and reactions performed in a mix containing Brilliant(R) II SYBR QPCR Low Rox Master Mix (Agilent Technologies, Waldbronn, Germany) and 200 nM of each primer on the Mx3000P QPCR System (Agilent Technologies, Waldbronn, Germany). PCR reaction conditions were: 10 min at 95˚C, followed by 40 cycles of 30 s at 95˚C, 60 s at 60˚C and 60 s at 72˚C. Data analysis was performed using MxPro TM QPCR Software (Agilent Technologies, Waldbronn, Germany). All data values were normalized to those for ubiquitin C (UBC). Primers used in this study are: Sox9 forward, 59-ACCAGTACCCGCACTTGCAC-39, and reverse, 59-CTTC-ACCGACTTCCTCCGCCG-39; Ubiquitin C, forward, 59-ATTTGGGT-CGCGGTTCTT-39 and reverse, 59-TGCCTTGACATTCTCGATGGT-39; fibronectin forward, 59-AAACTTGCATCTGGAGGCAAACCC-39 and reverse, 59-AGCTCTGATCAGCATGGACCACTT-39; and DTDST forward, 59-TTGTGTCATCCTCCGCACTCAGAA-39 and reverse, 59-TGATGCCTGGCTTAGTCTGAAGGT-39.
Cell lysis and immunoblotting
Cells were lysed in modified RIPA (mRIPA) buffer (WierzbickaPatynowski et al., 2007) , urea-SDS buffer (8M urea, 2% SDS, 2% bmercaptoethanol, 0.16 M Tris-HCl pH 6.8), SDS buffer (2% SDS, 20 mM Tris-HCl pH 8.8, 2 mM EDTA, 2 mM PMSF) or DOC buffer (2% DOC, 20 mM Tris-HCl pH 8.8, 2 mM EDTA, 2 mM PMSF) supplemented with protease inhibitor cocktail (Roche Diagnostics, Indianapolis, IN, USA). DOC lysates were separated into DOC-soluble and DOC-insoluble material by centrifugation at 11,000 g for 15 min. DOC-soluble fibronectin was compared in Fig. 3 because cells treated with DTDST siRNA do make detectable DOC-insoluble fibronectin matrix. For SDS lysis of ATDC5 cells, the SDS concentration in SDS buffer was increased to 4%. Total protein concentration was determined using a BCA protein assay (Pierce Chemical Co., Rockford, IL, USA). Normalized, reduced samples were separated by SDS-PAGE, and proteins were detected by immunoblotting. Antibodies and dilutions were: rabbit anti-GAPDH antibody (1:2000, Cell Signaling, Danvers, MA, USA), mouse anti-fibronectin hybridoma supernatant (HFN7.1, 1:10,000; Galante and Schwarzbauer, 2007) , R457 rabbit anti-fibronectin antiserum (1:2000, Aguirre et al., 1994) , anti-N-cadherin antibody (mouse monoclonal 3B9, 1:500, Life Technologies, Grand Island, NY, USA), horseradish-peroxidase-conjugated goat anti-rabbit-IgG or goat anti-mouse-IgG antibody (Pierce Chemical Co., Rockford, IL, USA, 1:10,000). Blots were developed using Super Signal West Pico Chemiluminescent substrate (Pierce Chemical Co., Rockford, IL, USA). Quantification of bands was done using Quantity One(R) software (Bio-Rad, Hercules, CA, USA).
siRNA transfection
Cells were plated in MSCBM at a density of 5000 cells/cm 2 . After 24 h, cells were transfected with 100 nM siRNAs for human fibronectin (siGENOME SMARTpool human FN1 siRNA, Thermo Scientific, Pittsburgh, PA, USA) or 120 nM siRNA for human DTDST in RNAiMax reagent (Life Technologies, Grand Island, NY, USA) (Galante and Schwarzbauer, 2007) . Cells were incubated with siRNA and RNAimax cocktail diluted in 1 ml of Optimem for 4 h and then supplemented with 500 ml of MSCBM. Controls included mocktransfected cells treated with RNAiMax without siRNAs or cells transfected with control siRNAs (siControl Non-targeting siRNA#1, Thermo Scientific, Pittsburgh, PA, USA). On the following day, cells were replated in complete medium and allowed to recover for 3 days before starting the chondrogenesis assay. Condensation was somewhat slower in cells that had been exposed to siRNA transfection reagents. Both mock and control siRNA-treated cells condensed by day 3, at least 24 h prior to condensation of the majority of cells treated with fibronectin siRNA, although mock-treated cells usually condensed 6-24 h earlier than control siRNA-treated cells. Levels of secreted fibronectin were not affected by either mock or control siRNA treatment. For fibronectin rescue experiments, exogenous rat plasma fibronectin was included at 10, 30 or 50 mg/ml in the high-density cultures as well as in the differentiation media.
Staining and microscopy
Pellet cultures from day 3 and 6 were embedded in optimal cutting temperature (OCT) medium (Electron Microscopy Sciences, Hatfield, PA, USA) and cryo-sectioned into 5-mm thick sections using a Leica CM 3050 S cryostat (Leica Biosystems, Buffalo Grove, IL, USA). Cells grown in monolayer for 24 h, micromass cultures grown on coverslips for 6 or 8 h or sections of condensed cultures were fixed in 3.7% (v/v) formaldehyde (Sigma, St. Louis, MO, USA) in PBS for 15 min at room temperature, washed with PBS, and blocked in 2% BSA in PBS for 1 h followed by incubation with HFN 7.1 (1:500) and Alexa-Fluor-488-conjugated goat anti-mouse-IgG antibody (1:500, Invitrogen Life Technologies, Eugene, OR, USA) in 1% BSA in PBS. Coverslips were mounted on slides using Fluor guard Anti-Fade reagent (Bio-Rad, Hercules, CA, USA). Visualization was performed using a Nikon TE2000U microscope (Chiyoda, Tokyo, Japan) equipped with a Cooke SensiCam QE High Performance camera using iVision software.
Condensed micromass cultures were washed in PBS and fixed in 95% methanol for 20 min followed by staining with 1% Alcian Blue stain in 0.1 M HCl overnight at 4˚C (Shukunami et al., 1996) , washed with 0.1 M HCl, and rinsed with distilled water. Stained pellets were imaged by brightfield microscopy using a Nikon Microphat SA microscope equipped with a Nikon DS1500 color camera (Chiyoda, Tokyo, Japan).
For time-lapse video microscopy, micromass cultures on glass-bottomed dishes (Greiner Bio-one, Frickenhausen, Germany) were visualized for 16 h from the time of induction using a Nikon A1RS microscope (Chiyoda, Tokyo, Japan) equipped with a motorized stage and a chamber with a forced-air heater, allowing for temperature and CO 2 control during timelapse image acquisition. Brightfield was utilized for image acquisition. Images were acquired every 10 min over a 16-h time interval using an Andor SC Mos monochrome camera. Nis Elements 2 and Image J software were employed for time-lapse image analysis. Supplemental movies are a compilation of every sixth frame of 94 frames.
Staining with Rhodamine-conjugated peanut agglutinin (Vector Laboratories, Burlingame, CA, USA) was performed on micromass cultures. Cells on coverslips were fixed in 4% paraformaldehyde in PBS for 30 min at 4˚C and stained with peanut agglutinin at 10 mg/ml in PBS for 2 h at room temperature. Coverslips were mounted and visualized as described above.
Statistical analysis
Graphs show average values of aggregated data. Error bars represent the relative standard error (s.e.m.), or standard deviation in those cases in which the experiment was performed twice. For statistical analyses, a two-tailed Students's t-test or N1 x 2 test was used.
Supplemental Movie Legends
Supplemental movie 1. MSCs induced to undergo condensation. Bright field, timelapse video microscopy was used to image MSCs for 16 hours after induction of chondrogenesis. One frame was captured every 10 min. Movie is a compilation of every sixth frame.
Supplemental movie 2. MSCs undergoing condensation in presence of III-11C
peptide. Bright field, time-lapse video microscopy was used to image MSCs for 16 hours after induction of chondrogenesis in the presence of 0.33 µM III-11C control peptide.
One frame was captured every 10 min. Movie is a compilation of every sixth frame.
Supplemental movie 3. MSCs undergoing condensation in presence of FUD peptide.
Bright field, time-lapse video microscopy was used to image MSCs for 16 hours after induction of chondrogenesis in the presence of 0.33 µM FUD peptide. One frame was captured every 10 min. Movie is a compilation of every sixth frame.
